Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malaria

Fig. 2

Changes in seroprevalence for five P. falciparum antigens (2018 vs 2017, by exposure group). Seroprevalence was estimated by fitting multilevel logistic regression models, with adjustment for age, use of a bednet the night before, size of the household, occupation of the head of the household and possession of livestock. Robust variance estimators were used, and models used random intercepts at the individual, household and commune levels. The intervention group refer to the individuals who self-reported having received MDA in 2018, while the control group refer to individuals who self-report not being exposed to MDA in 2018. No participant was exposed to MDA in 2017, whatever the group

Back to article page